Implementation and setup of a platform for the identification of new compounds with anti-coronavirus activity. 

The setting up of new screening models and platforms will allow to greatly expand the capacity of analysis of new anti-coronavirus compounds.

Having a screening platform together with the establishment of workflows, new models that will be able to be used in high throughput screening and secondary testing will contribute to generate knowledge in the area of discovering new antivirals. 

IP: Dolores González Pacanowska (IPBLN)  

We use cookies on this site to improve your user experience. More info. ACEPTAR

Aviso de cookies